Ascentage Pharma Group International American Depository Shares (AAPG)
Nasdaq: AAPG · Pharmaceutical Preparations · Suzhou , Jiangsu, CN · filing with the SEC since 2024
Who owns Ascentage Pharma Group International American Depository Shares
As filed with the SECHolders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
14
report now, of 14 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
No holder of 5% or more is on file in a Schedule 13D or 13G naming this company.
What AAPG reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Ascentage Pharma Group Inc
An entity · subsidiary · owns, named in the 20-F filed Apr 29, 2026
Guangzhou Healthquest Pharma Co Ltd
An entity · subsidiary · owns, named in the 20-F filed Apr 29, 2026
Suzhou Ascentage Pharma Co Ltd
An entity · subsidiary · owns, named in the 20-F filed Apr 29, 2026
Suzhou Shenghe Innovation Works Biotech Co Ltd
An entity · subsidiary · owns, named in the 20-F filed Apr 29, 2026
17 subsidiaries in 6 countries, from the list filed with the 20-F filed Apr 29, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.